{"url_path":"/sec/nxglw/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 EXHIBITS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1468929/0001493152-26-023207-index.html","accession_number":"0001493152-26-023207","cik":"0001468929","ticker":"NXGL","issuer_name":"NEXGEL, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1468929/0001493152-26-023207-index.html","primary_entity_key":"0001468929","primary_entity_name":"NEXGEL, INC."},"word_count":491,"has_tables":true,"body_markdown":"**ITEM\n6. EXHIBITS**\n\n \n\nSee\n“Index to Exhibits” for a description of our exhibits.\n\n \n\n**Index\nto Exhibits**\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n3.1\n \n[Certificate of Incorporation of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.1 to Form S-1, filed with the SEC on January 9, 2019).](https://www.sec.gov/Archives/edgar/data/1468929/000114420419001167/tv509486_ex3-1.htm)\n\n3.2\n \n[Certificate of Amendment to Certificate of Incorporation of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.2 to Form S-1, filed with the SEC on January 9, 2019).](https://www.sec.gov/Archives/edgar/data/1468929/000114420419001167/tv509486_ex3-2.htm)\n\n3.3\n \n[Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.3 to Amendment No. 1 to Form S-1, filed with the SEC on March 11, 2019).](https://www.sec.gov/Archives/edgar/data/1468929/000114420419013366/tv510774_ex3-3.htm)\n\n3.4\n \n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on November 14, 2019)](https://www.sec.gov/Archives/edgar/data/1468929/000110465919064281/tm1922973d1_ex3-1.htm)\n\n3.5\n \n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on May 29, 2020)](https://www.sec.gov/Archives/edgar/data/1468929/000110465920067638/tm2021383d1_ex3-1.htm)\n\n3.6\n \n[Certificate of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on August 2, 2021)](https://www.sec.gov/Archives/edgar/data/1468929/000110465921100492/tm2124153d1_ex3-1.htm)\n\n3.7\n \n[Amended and Restated Bylaws of AquaMed Technologies, Inc. (incorporated by reference to Exhibit 3.5 to Amendment No. 1 to Form S-1, filed with the SEC on March 11, 2019).](https://www.sec.gov/Archives/edgar/data/1468929/000114420419013366/tv510774_ex3-5.htm)\n\n31.1*\n \n[Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.](ex31-1.htm)\n\n31.2*\n \n[Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.](ex31-2.htm)\n\n32.1*\n \n[Certification of Chief Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm)\n\n32.2*\n \n[Certification of Chief Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-2.htm)\n\n101*\n \nThe\nfollowing materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter March 31, 2025, formatted in iXBRL\n(Inline eXtensible Business Reporting Language), (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Stockholders’\nEquity, (iv) Statements of Cash Flows, and (v) Notes to the Financial Statements.\n\n104*\n \nCover\nPage Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit).\n\n \n\n*\nFiled\nherewith.\n\n \n \n\n**\nCertain\nexhibits and schedules have been omitted and the Company agrees to furnish supplementary to the Securities and Exchange Commission\na copy of any omitted exhibits upon request.\n\n \n\n33\n\n[Table of Contents](#toc_001)\n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned thereunto duly authorized.\n\n \n\n \n**NEXGEL,\nINC.**\n\n \n \n \n\nDate:\nMay 14, 2026\nBy:\n*/s/\nAdam Levy*\n\n \nName:\nAdam\nLevy\n\n \nTitle:\nChief\nExecutive Officer\n\n \n \n(Principal\nExecutive Officer)\n\n \n \n \n\n \nBy:\n*/s/\nIan Blackman*\n\n \nName:\nIan\nBlackman\n\n \nTitle:\nChief\nFinancial Officer\n\n \n \n(Principal\nFinancial Officer)\n\n \n\n34"}